Synthesis, tissue distribution in rats and PET studies in baboon brain of no-carrier-added [18F]RU 52461: in vivo evaluation as a brain glucocorticoid receptor radioligand

Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Philippe Hantraye(Centre National de la Recherche Scientifique), O. Stulzaft(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), M. Khalili-Varasteh(Centre National de la Recherche Scientifique), C. Crouzel(Université de Bordeaux)
International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology
February 1, 1992
10.1016/0883-2897(92)90004-i
Cited by 9

Related Papers

The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina
|Molecular Therapy|2017|165
<sup>18</sup>F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to <sup>18</sup>F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
|Journal of Nuclear Medicine|2010|154
The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis
|Journal of Nuclear Cardiology|2013|87